Angel Yeast stock: Analyst Forecast
600298.SSFor Angel Yeast, analysts expect revenue of $2.87B (up 14.6%) and adjusted earnings per share of $0.29 (up 22.5%) on average for fiscal year 2026. For 2027 they expect revenue of $3.23B (up 12.3%) and adjusted earnings per share of $0.34 (up 17.6%). That is the average of the estimates of 10 analysts.
Daily figure as of 20 Nov 2026
Reported and Expected
| Fiscal year | Type | Revenue | Growth | Net income | Net margin | EPS | Analysts |
|---|---|---|---|---|---|---|---|
| 2023 | Reported | $2.04B | 5.8% | $190.91M | 9.4% | $0.22 | |
| 2024 | Reported | $2.28B | 11.9% | $198.69M | 8.7% | $0.23 | |
| 2025 | Reported | $2.51B | 10.1% | $231.66M | 9.2% | $0.27 | |
| 2026 | Estimate | $2.87B | 14.6% | $252.12M | 8.8% | $0.29 | 10 |
| 2027 | Estimate | $3.23B | 12.3% | $291.95M | 9.0% | $0.34 | 10 |
Earnings per share in the estimates are usually adjusted, the way analysts calculate them. The reported figure is the statutory one and can therefore differ.
What the Estimates Show
In 4 of 6 quarters, Angel Yeast missed the analysts' expectation for earnings per share and beat it once. For revenue, Angel Yeast beat the analysts' expectation in 2 of 8 quarters and missed it in 2. Earnings per share are expected to grow faster than revenue in 2026, by 22.5% against 14.6%.
The expected net margin stays at about 9% in 2026 and 2027. The expected revenue growth for 2026 of +14.6% is close to the average of fiscal years 2020 to 2025 of +13.4% per year. In the report of 30 Oct 2026, earnings per share came in line with the expectation (0.0%).
A reported figure within 2% of the expectation counts as in line.
How Angel Yeast Compares
Among the 201 other stocks in the Consumer Defensive sector with a forward P/E, the median is 16.2. At 17.1, Angel Yeast is above it.
Estimates of Industry Peers
Among industry peers, analysts expect the strongest revenue growth at Chocoladefabriken Lindt & Sprüngli (+3.3%) and the weakest at Hershey (+2.1%).
| Stock | Expected revenue growth | Forward P/E |
|---|---|---|
| Mondelez | +2.3% | 19.8 |
| Hershey | +2.1% | 18.6 |
| Chocoladefabriken Lindt & Sprüngli | +3.3% | 25.3 |
| Barry Callebaut | +2.9% | 22 |
Revenue growth here means the next fiscal year against the current one, both analyst averages.
Forecast and Fair Value
The forward P/E of Angel Yeast is 17.1, below the P/E on statutory earnings of the last twelve months (21.3). It uses the earnings analysts expect for the next twelve months. MEQIRI's fair value for Angel Yeast is $5.02, 13.5% below the share price. Its cash flow part uses the analysts' estimates for the first 3 years.
Why There Is No Price Target Here
MEQIRI deliberately does not show price targets or buy and sell recommendations, because they are opinions about the future share price. Revenue and earnings, by contrast, can be checked against every report.
Data and Required Disclosures
- ; time horizon around 12 months
- Rated Neutral since 7 Nov 2026; valuation signal Fairly valued since 7 Nov 2026
- Price: closing price of 20 Nov 2026
- Amounts in US dollars at the ECB reference rate of 19 Nov 2026 ($1 = CN¥6.6667)
- Data from Financial Modeling Prep (FMP) based on the company's reports, latest fiscal year 2025. MEQIRI calculates the score and fair value itself every night.
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
